Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Women of color in Northern Manhattan view hair care as important to their identity and culture, and education on harmful chemicals in hair products is needed.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Hirsutism causes significant psychological distress in women.

Post-finasteride syndrome's existence is uncertain; more research needed.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Doctors vary in how they initially test for PCOS, but most agree on using oral contraceptives and lifestyle changes as first treatments.

Androgen levels do not determine the type of PCOS symptoms in young females.

Teens with PCOS have a higher risk of type 2 diabetes and need regular glucose checks.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Dermatologists should address erectile dysfunction in patients with skin conditions to improve their quality of life.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

New treatments for male hypogonadism are effective and should be personalized.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.